Presented at the annual CELLS | Musculoskeletal 2016 conference in Amsterdam.
Jose Miguel Catalán, M.D., Severiano Dos Anjos Vilaboa, Ph.D.
This is a prospective interventional clinical study including 8 patients . For preparing the bone marrow concentrate a new disposable point-of-care medical device was used. The total nucleated cell count for each patient was measured and recorded as quality control
Pre and post-operative clinical outcomes overtime included the lower extremity functional scale (LEFS) and visual analog scale (VAS), as well as, MRI and Rx imaging during at least 6 months (ranging from 6 to 12 months). Download the abstract by clicking here: CELLS_Abstract_BMC_CatalanLeave a reply →